MedTrace Logo

Vitamin D, Cardiovascular Disease, and African Americans

NCT01655810 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2020-06-05

No results posted yet for this study

Summary

African-Americans have higher rates of cardiovascular disease morbidity and mortality, as well as vitamin D deficiency. Multiple observational studies have demonstrated an increased risk of vitamin D deficiency in African Americans with type 2 diabetes and correlation between cardiovascular disease and vitamin D levels; however, there is a lack of interventional trials exploring this connection. The objective of this proposal is to address the hypothesis that treatment of vitamin D deficiency in African Americans with type 2 diabetes will improve subclinical markers of cardiovascular disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Multivitamin containing cholecalciferol 4000 units orally daily

DIETARY_SUPPLEMENT

Vitamin D3

Multivitamin containing cholecalciferol 600 units orally daily

DIETARY_SUPPLEMENT

Calcium carbonate

500 mg orally twice daily

Sponsors & Collaborators

Principal Investigators

  • Carlos Bernal-Mizrachi, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-13
Primary Completion
2018-02-09
Completion
2018-02-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655810 on ClinicalTrials.gov